Trial intelligence / Profile preview

Influence of antihypertensive drugs on plasma free metanephrines

NL-OMON38391Active, not recruiting

Sponsor
University Medical Center Groningen
Start
Feb 2009
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of carvedilol in hypertension (HTN) (3 arms), sponsored by University Medical Center Groningen. Primary endpoints: Plasma free metanephrines and False-positive pheochromocytoma diagnostic potential. Started Feb 2009; status: active, not recruiting.

02

Drugs

carvedilol
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NL-OMON38391.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON38391.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call